Related Experiment Video
Updated: Jul 2, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
The relationship between vascular endothelial growth factor (VEGF) and microalbuminuria in patients with essential
Fatma Ayerden Ebinç1, Ebinç Haksun, Derici Boztepe Ulver
1Faculty of Medicine, Department of Nephrology, Gazi University. fayerdenebin@yahoo.com
Objective:
The existence of microalbuminuria (MAU) in patients with essential hypertension is a strong indicator of microvascular damage. Although endothelial dysfunction and increased vascular permeability both have a role in the development of MAU, its ethiopathogenesis in hypertensive patients is not yet clearly understood. Vascular endothelial growth factor (VEGF) is the most important regulator of pathological or physiological angiogenesis and it additionally leads to increased vascular permeability. This study aims to assess the relationship of serum VEGF levels to MAU in non-complicated, newly-diagnosed essential hypertensive patients (EHs).
Methods:
This study included 30 newly-diagnosed EHs with MAU, 46 newly-diagnosed EHs without MAU and 46 healthy controls. None of the EHs had diabetes, renal impairment or atherosclerotic diseases. Serum VEGF levels were measured using the ELISA method.
Results:
Serum levels of VEGF were significantly higher in EHs with MAU when compared with patients without MAU (225.15+/-109.34 pg/mL versus 166.78+/-114.35 pg/mL, p: 0.04) or controls (225.15+/-109.34 pg/mL versus 144.91+/-96.60 pg/mL, p: 0.007). On the other hand, no significant difference was observed between the non-MAU and control groups. In the univariate analysis, serum levels of VEGF, were positively correlated with systolic blood pressure (R: 0.253 p: 0.001), diastolic blood pressure (R: 0.162 p: 0.04), mean arterial pressure (R: 0.239 p: 0.002), creatinine clearance (R: 0.172 p: 0.04) and MAU (R: 0.338 p: 0.002). In the multiple linear regression analysis, VEGF levels were independently related to MAU (beta: 0.248, p: 0.02).
Conclusion:
VEGF levels are higher in EHs in the presence of MAU. These high values may be important in the early diagnosis of vascular damage in EHs. Additionally, VEGF may increase glomerular permeability and lead to MAU in EHs.
Insights
Serum vascular endothelial growth factor (VEGF) levels are elevated in patients with essential hypertension and microalbuminuria (MAU). This suggests VEGF may play a role in early vascular damage diagnosis in hypertensive individuals.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Microalbuminuria (MAU) in essential hypertension (EHs) indicates microvascular damage.
- Endothelial dysfunction and increased vascular permeability contribute to MAU pathogenesis.
- Vascular endothelial growth factor (VEGF) regulates angiogenesis and vascular permeability.
Purpose of the Study:
- To investigate the association between serum VEGF levels and MAU in newly-diagnosed, uncomplicated essential hypertensive patients.
- To explore VEGF's role in the early stages of vascular damage in hypertension.
Main Methods:
- Study included 30 EHs with MAU, 46 EHs without MAU, and 46 healthy controls.
- Exclusion criteria: diabetes, renal impairment, atherosclerotic diseases.
- Serum VEGF levels were quantified using the ELISA method.
Main Results:
- Serum VEGF levels were significantly higher in EHs with MAU compared to EHs without MAU (p=0.04) and controls (p=0.007).
- No significant difference in VEGF levels was found between non-MAU EHs and controls.
- VEGF levels positively correlated with systolic blood pressure, diastolic blood pressure, mean arterial pressure, creatinine clearance, and MAU (p<0.05).
- Multiple regression analysis confirmed VEGF was independently related to MAU (p=0.02).
Conclusions:
- Elevated serum VEGF levels are associated with the presence of MAU in essential hypertension.
- High VEGF may serve as an early biomarker for vascular damage in hypertensive patients.
- VEGF might contribute to increased glomerular permeability, leading to MAU in EHs.
Related Concept Videos
Diabetic Nephropathy
Regulation of Angiogenesis and Blood Supply
Diabetic Retinopathy
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
